Variables | CHM (n = 106) | placebo (n = 54) | P Values |
---|---|---|---|
Characteristic | P > 0.05 | ||
Age(year) | 39.48 ±13.75 | 41.63 ± 12.31 | |
Sex ratio(male:female) | 35:71 | 15:39 | |
Height(Cm) | 164.94 ± 7.41 | 164.57 ± 7.01 | |
Weight(Kg) | 58.25 ± 10.04 | 58.91 ± 9.85 | |
Course of disease(month) | 43.24 ± 51.41 | 45.30 ± 65.42 | |
TDS and SDS scores (week 0) | |||
Gastroenterologist TDS scores | 6.58 ± 2.23 | 6.61 ± 2.11 | |
Patient TDS scores | 6.56 ± 2.18 | 6.81 ± 2.31 | |
Gastroenterologist SDS scores | |||
Epigastric pain | 3.32 ± 2.27 | 2.85 ± 2.10 | |
Epigastric burning | 0.98 ± 1.74 | 0.96 ± 1.67 | |
Postprandial fullness and bloating | 5.04 ± 1.97 | 5.25 ± 1.96 | |
Early satiety | 3.35 ± 2.39 | 3.69 ± 2.33 | |
Patient SDS scores | |||
Epigastric pain | 3.25 ± 2.28 | 2.96 ± 2.27 | |
Epigastric burning | 1.00 ± 1.76 | 1.02 ± 1.79 | |
Postprandial fullness and bloating | 5.02 ± 1.93 | 5.19 ± 1.94 | |
Early satiety | 3.33 ± 2.37 | 3.76 ± 2.44 |